Active, not recruitingNot applicableNCT04774913

Invest-CTO PCI Trial

Studying PLA2G6-associated neurodegeneration

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Haukeland University Hospital
Principal Investigator
Margaret B Mcentegart, PhD
Golden Jubilee National Hospital
Intervention
Chronic total occlusion(CTO) percutaneous coronary intervention (PCI)(procedure)
Enrollment
200 target
Eligibility
18 years · All sexes
Timeline
20212026

Study locations (5)

Collaborators

Golden Jubilee National Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04774913 on ClinicalTrials.gov

Other trials for PLA2G6-associated neurodegeneration

Additional recruiting or active studies for the same condition.

See all trials for PLA2G6-associated neurodegeneration

← Back to all trials